News
The three companies issued stop work orders are developing COVID-19 vaccines that use new technology to improve effectiveness ...
Six posters highlight continued progress across antibody-drug conjugate and T cell engager platforms Novel T cell engager ZW209 demonstrates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback